Category list : Anti-inflammatory agents
Sort by: Newest first Oldest first A-Z Z-A
-
Everything you need to know about the COVID-19 therapy trials
Researchers around the world are working at record speed to find the best ways to treat and prevent COVID-19, from investigating the possibility of repurposing existing drugs to searching for novel therapies against the virus.
-
Anti-inflammatory drugs found to exert antidepressant effect Subscription
Anti-inflammatory agents exert an antidepressive effect in the treatment of major depressive disorder, a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery and Psychiatry has suggested.
-
NICE recommends aspirin for cancer prevention for the first time Subscription
Aspirin has been recommended for cancer prevention in draft national clinical guidance for the first time.
-
Prednisolone reduces hand osteoarthritis pain Subscription
Patients with hand osteoarthritis experienced improvements in pain and function with low-dose prednisolone treatment, according to a study presented at the European Congress of Rheumatology.
-
Management of acute upper gastrointestinal bleeding Subscription
An overview of the assessment process for acute upper gastrointestinal bleeding in the hospital setting and the treatment options available.
-
Study results do not support use of hydroxychloroquine in hand osteoarthritis Subscription
There is anecdotal evidence that the slow-acting anti-inflammatory treatment hydroxychloroquine, used to treat rheumatoid arthritis, could also be effective in osteoarthritis.
-
A brief history of ibuprofen Subscription
This timeline traces the history of popular anti-inflammatory drug ibuprofen, from its invention in the 1960s to its association with cardiac side effects.
-
High-dose vitamin D counteracts sunburn damage Subscription
A double-blinded, placebo-controlled interventional trial reveals high-dose vitamin D3 as a potent modulator of experimental sunburn induced by simulated solar radiation.
-
Ustekinumab approved by NICE for treatment of Crohn’s disease
The National Institute of Health and Care Excellence (NICE) has approved ustekinumab (Stelara; Janssen) as a treatment for patients with moderate to severe Crohn’s disease who have had little or no response, or an intolerance, to existing therapies.
